| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NanoString Technologies Inc | Chief Commercial Officer | Restricted Stock Units | 0 | $437,800 | $2.19 | 06 May 2024 | Direct |
| Cytek Biosciences, Inc. | Chief Commercial Officer | Restricted Stock Units | 39,579 | $236,682 | $5.98 | 18 Aug 2023 | Direct |
| Cytek Biosciences, Inc. | Chief Commercial Officer | Common Stock | 8,763 | $83,249 | $9.50 | 18 Aug 2023 | Direct |
| NanoString Technologies Inc | Chief Commercial Officer | Common Stock | 200,000 | 06 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000140170824000086-garland-jonathan-todd-2024-05-06 | NanoString Technologies Inc | 06 May 2024 | 2 | $0 | 4 | Chief Commercial Officer | 08 May 2024, 20:48 |
| /report/000140170823000210-garland-jonathan-todd-2023-08-28 | NanoString Technologies Inc | 28 Aug 2023 | 1 | $0 | 4 | Chief Commercial Officer | 28 Aug 2023, 16:26 |
| /report/000140170823000208-garland-jonathan-todd-2023-08-28 | NanoString Technologies Inc | 28 Aug 2023 | 0 | $0 | 3 | Chief Commercial Officer | 28 Aug 2023, 16:22 |
| CTKB | Cytek Biosciences, Inc. | 18 Aug 2023 | 6 | -$15,533 | 4 | Chief Commercial Officer | 21 Aug 2023, 20:10 |
| CTKB | Cytek Biosciences, Inc. | 18 May 2023 | 6 | -$25,134 | 4 | Chief Commercial Officer | 19 May 2023, 19:02 |
| CTKB | Cytek Biosciences, Inc. | 03 Mar 2023 | 2 | $0 | 4 | Chief Commercial Officer | 07 Mar 2023, 18:45 |
| CTKB | Cytek Biosciences, Inc. | 25 Apr 2022 | 2 | $0 | 4 | Chief Commercial Officer | 27 Apr 2022, 20:07 |
| CTKB | Cytek Biosciences, Inc. | 25 Apr 2022 | 0 | $0 | 3 | Chief Commercial Officer | 27 Apr 2022, 20:03 |